Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | Tofacitinib | 0.3 | uM | 4 | SCGF-b | 233.0 | 70 | ||||
N2645 | 4 | SCGF-b | 245.0 | 59 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | SCGF-b | 117.0 | 53 | ||||
RA2708 | 4 | SCGF-b | 97.0 | 43 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 133.5 | 52 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 129.0 | 46 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 205.0 | 56 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 186.0 | 62 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 99.0 | 45 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 116.0 | 53 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 140.0 | 51 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 128.0 | 63 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 251.0 | 44 | |
N2645 | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 222.0 | 59 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 125.0 | 70 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 4 | SCGF-b | 111.0 | 42 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 179.0 | 61 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 139.0 | 45 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 257.0 | 62 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 211.0 | 53 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 124.0 | 72 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 140.0 | 75 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 170.5 | 56 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 155.5 | 48 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | SCGF-b | 325.0 | 63 |